Clinical trial
Dexmedetomidine Continuous Intravenous Infusion vs. Remifentanil Target-controlled Infusion Conscious Sedation for Stapedotomy/Stapedectomy- a Prospective, Single-center, Double-masked Randomized Trial
NCT06283836 is registered in ClinicalTrials.gov with Iuliu Hatieganu University of Medicine and Pharmacy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine Continuous Intravenous Infusion vs. Remifentanil Target-controlled Infusion Conscious Sedation for Stapedotomy/Stapedectomy- a Prospective, Single-center, Double-masked Randomized Trial
- Lead sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2024
- Completion date
- March 10, 2025
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.